The Protective Effects of Terpinen-4-ol on LPS-Induced Acute Lung Injury via Activating PPAR-γ

Inflammation. 2018 Dec;41(6):2012-2017. doi: 10.1007/s10753-018-0844-1.

Abstract

Terpinen-4-ol, the major constituent of tea tree oil, has been reported to have anti-inflammatory effect. However, whether terpinen-4-ol could attenuate LPS-induced inflammation in lung tissues remains unclear. In the present study, we aimed to investigate the protective effects of terpinen-4-ol on LPS-induced acute lung injury (ALI) in mice. Terpinen-4-ol could inhibit LPS-induced ALI as confirmed by the decreased lung histopathological changes, MPO activity, and lung W/D ratio caused by terpinen-4-ol. The production of TNF-α and IL-1β in the BALF was suppressed by the treatment of terpinen-4-ol. Western blot analysis showed that terpinen-4-ol significantly attenuated LPS-induced phosphorylation of IκBα and NF-κB p65. Furthermore, the expression of PPAR-γ was dose-dependently upregulated by the treatment of terpinen-4-ol. In conclusion, the results of this study indicated that terpinen-4-ol inhibited LPS-induced ALI via activating PPAR-γ, which subsequently attenuated LPS-induced NF-κB activation and inflammatory response.

Keywords: LPS; NF-κB; PPAR-γ; lung injury; terpinen-4-ol.

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / drug therapy
  • Acute Lung Injury / pathology*
  • Animals
  • Inflammation / prevention & control*
  • Lipopolysaccharides
  • Mice
  • NF-kappa B / drug effects
  • NF-kappa B / metabolism
  • PPAR gamma / drug effects
  • PPAR gamma / metabolism*
  • Protective Agents / pharmacology
  • Terpenes / pharmacology*

Substances

  • Lipopolysaccharides
  • NF-kappa B
  • PPAR gamma
  • Protective Agents
  • Terpenes
  • terpinenol-4